The Central Drugs Standard Control Organisation has sent a three-member team to Jaipur to inquire into an alleged unethical human clinical trial conducted by a pharma company at a private hospital in the Rajasthan capital, the Drugs Controller General of India (DCGI) said on Saturday.State panel Rajasthan Health Minister Kalicharan Saraf also constituted a three-member panel to probe into the alleged incident. According to State officials, nearly two dozen people hailing from Rajasthan’s Churu and Bharatpur districts were allegedly subjected to the unethical human clinical trial for an osteo-ortho drug at the hospital. DCGI Dr. S. Eswara Reddy, in Delhi, said, “We have sent a team of three officials to Jaipur to inquire into the matter along with the State drug controller.” Mr. Saraf said a three-member panel, headed by an additional director-level officer has been constituted to probe the matter. “Action will be taken, if lapses are found, the Health Minister said. Hospital visitedThe panel on Saturday visited the hospital located in Vishwakarma Industrial Area to initiate the probe. “Principal investigator and patients enrolled in the clinical trial were not available at the site. We have asked the hospital staff to provide necessary documents related to the trial,” Dr. Ravi Prakash Sharma, the head of the three-member probe panel constituted by the State government, said.